Harvard Apparatus Regenerative Technology, Inc. (HRGN) stock
HRGNOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$2.21−0.02 (-0.72%)
Close on Oct 19, 2026Market cap $38.92MP/E –Yield –
Harvard Apparatus Regenerative Technology operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Harvard Apparatus Regenerative Technology's operating income for the twelve months ending Jun 30, 2026 was -$6.71M. For fiscal 2025 it was -$6.92M. The highest annual figure on record is -$5.33M in fiscal 2020.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$6.92M | – |
| FY2024 | Dec 31, 2024 | -$7.73M | – |
| FY2023 | Dec 31, 2023 | -$8.99M | – |
| FY2022 | Dec 31, 2022 | -$6.15M | – |
| FY2021 | Dec 31, 2021 | -$8.64M | – |
| FY2020 | Dec 31, 2020 | -$5.33M | – |
| FY2019 | Dec 31, 2019 | -$8.87M | – |
| FY2018 | Dec 31, 2018 | -$7.84M | – |
| FY2017 | Dec 31, 2017 | -$11.47M | – |
| FY2016 | Dec 31, 2016 | -$12.13M | – |
| FY2015 | Dec 31, 2015 | -$11.70M | – |
| FY2014 | Dec 31, 2014 | -$11.06M | – |
| FY2013 | Dec 31, 2013 | -$8.82M | – |
| FY2012 | Dec 31, 2012 | -$6.71M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$1.69M | – |
| Q1 FY2026 | Mar 31, 2026 | -$1.61M | – |
| Q4 FY2025 | Dec 31, 2025 | -$1.70M | – |
| Q3 FY2025 | Sep 30, 2025 | -$1.71M | – |
| Q2 FY2025 | Jun 30, 2025 | -$1.83M | – |
| Q1 FY2025 | Mar 31, 2025 | -$1.67M | – |
| Q4 FY2024 | Dec 31, 2024 | -$1.37M | – |
| Q3 FY2024 | Sep 30, 2024 | -$1.86M | – |
| Q2 FY2024 | Jun 30, 2024 | -$2.48M | – |
| Q1 FY2024 | Mar 31, 2024 | -$2.02M | – |
| Q4 FY2023 | Dec 31, 2023 | -$1.83M | – |
| Q3 FY2023 | Sep 30, 2023 | -$1.62M | – |
| Q2 FY2023 | Jun 30, 2023 | -$2.65M | – |
| Q1 FY2023 | Mar 31, 2023 | -$2.89M | – |
| Q4 FY2022 | Dec 31, 2022 | -$1.49M | – |
| Q3 FY2022 | Sep 30, 2022 | -$1.08M | – |
| Q2 FY2022 | Jun 30, 2022 | -$1.38M | – |
| Q1 FY2022 | Mar 31, 2022 | -$2.21M | – |
| Q4 FY2021 | Dec 31, 2021 | -$5.90M | – |
| Q3 FY2021 | Sep 30, 2021 | -$822.00K | – |
| Q2 FY2021 | Jun 30, 2021 | -$918.00K | – |
| Q1 FY2021 | Mar 31, 2021 | -$995.00K | – |
| Q4 FY2020 | Dec 31, 2020 | -$1.11M | – |
| Q3 FY2020 | Sep 30, 2020 | -$1.06M | – |
| Q2 FY2020 | Jun 30, 2020 | -$1.26M | – |
| Q1 FY2020 | Mar 31, 2020 | -$1.90M | – |
| Q4 FY2019 | Dec 31, 2019 | -$1.67M | – |
| Q3 FY2019 | Sep 30, 2019 | -$2.50M | – |
| Q2 FY2019 | Jun 30, 2019 | -$2.67M | – |
| Q1 FY2019 | Mar 31, 2019 | -$2.03M | – |
| Q4 FY2018 | Dec 31, 2018 | -$2.10M | – |
| Q3 FY2018 | Sep 30, 2018 | -$2.23M | – |
| Q2 FY2018 | Jun 30, 2018 | -$2.03M | – |
| Q1 FY2018 | Mar 31, 2018 | -$1.48M | – |
| Q4 FY2017 | Dec 31, 2017 | -$1.44M | – |
| Q3 FY2017 | Sep 30, 2017 | -$3.25M | – |
| Q2 FY2017 | Jun 30, 2017 | -$3.73M | – |
| Q1 FY2017 | Mar 31, 2017 | -$3.05M | – |
| Q4 FY2016 | Dec 31, 2016 | -$3.58M | – |
| Q3 FY2016 | Sep 30, 2016 | -$3.15M | – |
See a number that looks wrong?